{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T19:07:52Z","timestamp":1788376072187,"version":"build-2803163510"},"reference-count":40,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Cryptococcosis, caused by Cryptococcus neoformans, remains a major cause of mortality in immunocompromised patients, with treatment increasingly limited by resistance and toxicity associated with Amphotericin B (Amp B). In this study, methylglyoxal (MG) was evaluated as a virulence-targeted antifungal strategy, with emphasis on its liposomal delivery. MG exhibited superior antifungal activity as compared to Amp B, demonstrating lower MIC values and significantly enhanced inhibition of biofilm formation and laccase activity, key determinants of cryptococcal pathogenicity. Notably, MG showed potent intracellular antifungal activity within macrophages, where C. neoformans persists. Liposomal MG (Lip-MG) markedly reduced macrophage-associated fungal burden under the tested conditions, markedly outperforming both free MG and Amp B formulations. In a leukopenic mouse model of systemic infection, liposomal MG significantly improved survival (up to ~70%) and reduced pulmonary fungal burden as compared to Amp B, which showed limited therapeutic benefit. Importantly, MG-based formulations exhibited a favorable safety profile, with significantly lower nephrotoxicity than Amp B. Collectively, these findings demonstrate that Lip-MG acts through a dual virulence-targeted activity mechanism while effectively eliminating intracellular infection. This dual action, combined with improved safety, highlights MG-based nanotherapy as a promising and translational alternative for the treatment of drug-resistant cryptococcosis.<\/jats:p>","DOI":"10.3390\/ijms27114773","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:16:08Z","timestamp":1779783368000},"page":"4773","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Liposomal Methylglyoxal Targets Virulence and Intracellular Persistence to Overcome Amphotericin B Resistance in Cryptococcus neoformans"],"prefix":"10.3390","volume":"27","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4031-4189","authenticated-orcid":false,"given":"Masood Alam","family":"Khan","sequence":"first","affiliation":[{"name":"Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4528-2668","authenticated-orcid":false,"given":"Arif","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Basic Health Sciences, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4623-9557","authenticated-orcid":false,"given":"Mohd","family":"Azam","sequence":"additional","affiliation":[{"name":"Department of Medical Laboratories, College of Applied Medical Sciences, Qassim University, Buraydah 51452, Saudi Arabia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Md Zafar","family":"Iqubal","sequence":"additional","affiliation":[{"name":"Interdisciplinary Biotechnology Unit, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3066-1312","authenticated-orcid":false,"given":"Hina","family":"Younus","sequence":"additional","affiliation":[{"name":"Interdisciplinary Biotechnology Unit, Faculty of Life Sciences, Aligarh Muslim University, Aligarh 202002, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1086\/323895","article-title":"Trends in the epidemiology of opportunistic fungal infections: Predisposing factors and the impact of antimicrobial use practices","volume":"33","author":"Singh","year":"2001","journal-title":"Clin. Infect. Dis."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1093\/clinids\/17.5.837","article-title":"Cryptococcal meningitis and AIDS","volume":"17","author":"Powderly","year":"1993","journal-title":"Clin. Infect. Dis."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"5684","DOI":"10.1128\/IAI.70.10.5684-5694.2002","article-title":"Relationship of the glyoxylate pathway to the pathogenesis of Cryptococcus neoformans","volume":"70","author":"Rude","year":"2002","journal-title":"Infect. Immun."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"5484","DOI":"10.1016\/j.radcr.2025.07.011","article-title":"Cryptococcus gattii infection in an immunocompetent patient","volume":"20","author":"Fegahli","year":"2025","journal-title":"Radiol. Case Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1086\/649858","article-title":"Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America","volume":"50","author":"Perfect","year":"2010","journal-title":"Clin. Infect. Dis."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.2217\/fmb.12.102","article-title":"Mechanisms of infection by the human fungal pathogen Cryptococcus neoformans","volume":"7","author":"Sabiiti","year":"2012","journal-title":"Future Microbiol."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1086\/341564","article-title":"Pathogenesis of cerebral Cryptococcus neoformans infection after fungemia","volume":"186","author":"Lortholary","year":"2002","journal-title":"J. Infect. Dis."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Howard-Jones, A.R., Sparks, R., Pham, D., Halliday, C., Beardsley, J., and Chen, S.C. (2022). Pulmonary cryptococcosis. J. Fungi, 8.","DOI":"10.3390\/jof8111156"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"e02311","DOI":"10.1016\/j.idcr.2025.e02311","article-title":"An unusual clinical presentation of cryptococcal meningitis: The importance of a detailed history and physical","volume":"41","author":"Nakahira","year":"2025","journal-title":"IDCases"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e00725-13","DOI":"10.1128\/mBio.00725-13","article-title":"Efficacy of an abbreviated induction regimen of amphotericin B deoxycholate for cryptococcal meningoencephalitis: Three days of therapy is equivalent to 14 days","volume":"5","author":"Livermore","year":"2014","journal-title":"mBio"},{"key":"ref_11","doi-asserted-by":"crossref","unstructured":"Akinosoglou, K., Rigopoulos, E.A., Papageorgiou, D., Schinas, G., Polyzou, E., Dimopoulou, E., Gogos, C., and Dimopoulos, G. (2024). Amphotericin B in the era of new antifungals: Where will it stand?. J. Fungi, 10.","DOI":"10.3390\/jof10040278"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"e43862","DOI":"10.1097\/MD.0000000000043862","article-title":"The treatment of amphotericin B-resistant C neoformans meningitis: A case report and literature review","volume":"104","author":"Long","year":"2025","journal-title":"Medicine"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Pruitt, H.M., Zhu, J.C., Riley, S.P., and Shi, M. (2025). The hidden fortress: A comprehensive review of fungal biofilms with emphasis on Cryptococcus neoformans. J. Fungi, 11.","DOI":"10.3390\/jof11030236"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Basak, S., and Das, T.K. (2025). Liposome-based drug delivery systems: From laboratory research to industrial production\u2014Instruments and challenges. ChemEngineering, 9.","DOI":"10.3390\/chemengineering9030056"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"120571","DOI":"10.1016\/j.ijpharm.2021.120571","article-title":"Design of liposomes as drug delivery systems for therapeutic applications","volume":"601","author":"Nogueira","year":"2021","journal-title":"Int. J. Pharm."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s40265-016-0538-7","article-title":"Liposomal amphotericin B (AmBisome\u00ae): A review of the pharmacokinetics, pharmacodynamics, clinical experience and future directions","volume":"76","author":"Stone","year":"2016","journal-title":"Drugs"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1093\/jac\/dkl177","article-title":"Toxicity, stability and pharmacokinetics of amphotericin B in immunomodulator tuftsin-bearing liposomes in a murine model","volume":"58","author":"Khan","year":"2006","journal-title":"J. Antimicrob. Chemother."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Khan, M.A., Khan, A., Azam, M., Allemailem, K.S., Alrumaihi, F., Almatroudi, A., Alhumaydhi, F.A., Azam, F., Khan, S.H., and Zofair, S.F.F. (2021). Liposomal ellagic acid alleviates cyclophosphamide-induced toxicity and eliminates systemic Cryptococcus neoformans infection in leukopenic mice. Pharmaceutics, 13.","DOI":"10.3390\/pharmaceutics13060882"},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Zheng, L., Xu, Y., and Guo, L. (2024). Unveiling genome plasticity as a mechanism of non-antifungal-induced antifungal resistance in Cryptococcus neoformans. Front. Microbiol., 15.","DOI":"10.3389\/fmicb.2024.1470454"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1515\/DMDI.2008.23.1-2.175","article-title":"A brief critical overview of the biological effects of methylglyoxal and further evaluation of a methylglyoxal-based anticancer formulation in treating cancer patients","volume":"23","author":"Talukdar","year":"2008","journal-title":"Drug Metab. Drug Interact."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1002\/alr.20073","article-title":"Methylglyoxal (active agent of manuka honey) in vitro activity against bacterial biofilms","volume":"1","author":"Kilty","year":"2011","journal-title":"Int. Forum Allergy Rhinol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"3681","DOI":"10.2147\/IJN.S249625","article-title":"Potential of methylglyoxal-conjugated chitosan nanoparticles in treatment of fluconazole-resistant Candida albicans infection in a murine model","volume":"15","author":"Khan","year":"2020","journal-title":"Int. J. Nanomed."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3107","DOI":"10.1128\/AAC.06252-11","article-title":"Cryptococcus neoformans-Cryptococcus gattii species complex: An international study of wild-type susceptibility endpoint distributions and epidemiological cutoff values for amphotericin B and flucytosine","volume":"56","author":"Pfaller","year":"2012","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.cellimm.2013.11.006","article-title":"Immunomodulation of macrophages by methylglyoxal conjugated with chitosan nanoparticles against Sarcoma-180 tumor in mice","volume":"287","author":"Chakrabarti","year":"2014","journal-title":"Cell. Immunol."},{"key":"ref_25","doi-asserted-by":"crossref","unstructured":"Hern\u00e1ndez-Ch\u00e1vez, M.J., P\u00e9rez-Garc\u00eda, L.A., Ni\u00f1o-Vega, G.A., and Mora-Montes, H.M. (2017). Fungal strategies to evade the host immune recognition. J. Fungi, 3.","DOI":"10.3390\/jof3040051"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12934-024-02369-2","article-title":"Deciphering antifungal and antibiofilm mechanisms of isobavachalcone against Cryptococcus neoformans through RNA-seq and functional analyses","volume":"23","author":"Qian","year":"2024","journal-title":"Microb. Cell Fact."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"e02085-20","DOI":"10.1128\/mBio.02085-20","article-title":"Laccase Affects the Rate of Cryptococcus neoformans Nonlytic Exocytosis from Macrophages","volume":"11","author":"Sousa","year":"2020","journal-title":"mBio"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1128\/AAC.50.3.1021-1033.2006","article-title":"Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro","volume":"50","author":"Martinez","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1128\/AAC.46.11.3394-3400.2002","article-title":"Melanization of Cryptococcus neoformans and Histoplasma capsulatum reduces their susceptibilities to amphotericin B and caspofungin","volume":"46","author":"Casadevall","year":"2002","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"3165","DOI":"10.1073\/pnas.052702799","article-title":"Replication of Cryptococcus neoformans in macrophages is accompanied by phagosomal permeabilization and accumulation of vesicles containing polysaccharide in the cytoplasm","volume":"99","author":"Tucker","year":"2002","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1080\/1061186X.2020.1803333","article-title":"Coadministration of liposomal methylglyoxal increases the activity of amphotericin B against Candida albicans in leukopenic mice","volume":"29","author":"Khan","year":"2021","journal-title":"J. Drug Target."},{"key":"ref_32","first-page":"149","article-title":"Clinical hepatotoxicity associated with antifungal agents","volume":"16","author":"Kyriakidis","year":"2017","journal-title":"Expert Opin. Drug Saf."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"7224","DOI":"10.1128\/AAC.01698-15","article-title":"Toxicity of amphotericin B deoxycholate-based induction therapy in patients with HIV-associated cryptococcal meningitis","volume":"59","author":"Bicanic","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_34","first-page":"e16445","article-title":"Conventional amphotericin B-associated nephrotoxicity in patients with hematologic malignancies","volume":"13","author":"Gursoy","year":"2021","journal-title":"Cureus"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"27","DOI":"10.55133\/eji.320103","article-title":"Efficacy of liposomal amphotericin B in treating fungal meningitis in AIDS patients: A review article","volume":"32","author":"Khan","year":"2025","journal-title":"Egypt. J. Immunol."},{"key":"ref_36","unstructured":"Clinical and Laboratory Standards Institute (CLSI) (2007). Reference Method for Broth Dilution Antifungal Susceptibility Testing of Yeasts: Approved Standard, Clinical and Laboratory Standards Institute. [3rd ed.]."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"12951","DOI":"10.3390\/cimb46110771","article-title":"In silico and in vitro studies to explore the effect of thymoquinone on isocitrate lyase, biofilm formation, and the expression of some virulence genes in Candida albicans","volume":"46","author":"Khan","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2147\/IDR.S344246","article-title":"In Vitro Antifungal Activity of a Novel Antimicrobial Peptide AMP-17 Against Planktonic Cells and Biofilms of Cryptococcus neoformans","volume":"15","author":"Yang","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1016\/j.ijbiomac.2022.04.060","article-title":"In silico and in vitro studies on the inhibition of laccase activity by ellagic acid: Implications in drug designing for the treatment of cryptococcal infections","volume":"209","author":"Azam","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Allemailem, K.S., Almatroudi, A., Alrumaihi, F., Aljaghwani, A., Alnuqaydan, A.M., Khalilullah, H., Younus, H., El-Kady, A.M., Aldakheel, F.M., and Khan, A.A. (2021). Antimicrobial, immunomodulatory and anti-inflammatory potential of liposomal thymoquinone: Implications in the treatment of bacterial pneumonia in immunocompromised mice. Biomedicines, 9.","DOI":"10.3390\/biomedicines9111673"}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4773\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T08:21:30Z","timestamp":1779783690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/27\/11\/4773"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":40,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ijms27114773"],"URL":"https:\/\/doi.org\/10.3390\/ijms27114773","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]}}}